[Federal Register Volume 70, Number 174 (Friday, September 9, 2005)]
[Notices]
[Pages 53664-53665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-17892]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-05-0398X]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-371-5983 
and send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to <a href="/cdn-cgi/l/email-protection#107f7d72507374733e777f66"><span class="__cf_email__" data-cfemail="711e1c13311215125f161e07">[email protected]</span></a>.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Evaluation of an Intervention to Increase Colorectal Cancer 
Screening in Primary Care Clinics--New--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC).
    Background and Brief Description: Colorectal cancer (CRC) is the 
third most frequent form of cancer and the second leading cause of 
cancer-related deaths among both men and women in the United States. 
Research shows that screening can reduce both the occurrence of 
colorectal cancer and colorectal cancer deaths. Screening is beneficial 
for: (1) Detection and removal of precancerous polyps, resulting in 
patients recovering without progression to a diagnosis of cancer, and 
(2) early detection of CRC for more effective treatment and improved 
survival. Regular CRC screening is recommended for people aged 50 years 
and older. Many screening tests are widely available and screening has 
been shown to be effective in reducing CRC mortality. Despite this 
demonstrated effectiveness, CRC screening remains low. Some reasons 
attributed to the low screening rates include limited public awareness 
of CRC and the benefits of screening, failure of health care providers 
to recommend screening to patients, and inefficient surveillance and 
support systems in many health care settings.
    The purpose of this study is to evaluate and understand the effect 
of a multi-component intervention on CRC screening rates in primary 
care clinics. The study will also examine the effects of the 
intervention conditions on behavioral outcomes (e.g., clinician-patient 
discussions about CRC screening) and on attitudes, beliefs, opinions, 
and social influence surrounding CRC screening among patients, 
clinicians, and clinic support staff. The target population includes 
average-risk patients aged 50-80 years, clinicians, and clinic support 
staff within the primary care clinics in two managed care organizations 
(MCOs).
    There are three tasks in this study. In Task 1, 180 primary care 
clinicians will complete a survey assessing demographics; opinions 
about preventive services; CRC screening training and practices; 
satisfaction with CRC screening; and CRC screening beliefs, 
facilitators, and barriers. The survey will be administered to primary 
care clinicians pre- and post-intervention. In Task 2, 180 clinic 
support staff will complete a survey assessing demographics; work-
related responsibilities; opinions about preventive services; CRC 
training and practices; satisfaction with CRC screening; and CRC 
screening beliefs, facilitators, and barriers. The survey will be 
administered to clinic support staff pre- and post intervention. In 
Task 3, clinic patients will complete a survey assessing demographics, 
health status; receipt of previous CRC screening and other preventive 
services; knowledge and opinions about CRC and CRC screening; and 
social support. The survey will be administered to 4,252 patients pre-
intervention baseline and 4,252 patients post-intervention follow-up. 
We are requesting OMB clearance for one year. There are no costs to 
respondents other than their time.

                                    Estimate of Annualized Burden Hours Table
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
                   Respondents                      respondents    responses per   response  (in    (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Clinicians......................................             180               2           30/60             180
Clinic Support Staff............................             180               2           25/60             150
Patients surveyed only at baseline..............            3002               1           20/60           1,001
Patients surveyed at baseline and follow-up.....            1250               2           20/60             833
Patients surveyed only at follow-up.............            3002               1           20/60           1,001
----------------------------------------------------------------------------------------------------------------



[[Page 53665]]

    Dated: August 31, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 05-17892 Filed 9-8-05; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>